"We have a good chance that we will know if the product works by the end of October"—Pfizer CEO Albert Bourla discussing his company's potential coronavirus vaccine. Bourla thinks regulators could approve the drug before 2021.
The U.S. enters a pact with Pfizer for 100 million doses of a COVID-19 vaccine which Americans will receive for freeBy Michael Krewson
Hello guest! Please register or sign in (it's free) to view the hidden content. In signing a $2 billion deal to supply their experimental coronavirus vaccine to the U.S., Pfizer Inc.and BioNTech SE are setting a price ceiling of less than $20 a dose that will impact how much other companies can charge to protect people from Covid-19.
Interestingly, the CEO went into this saying that this wouldn’t be a profitable endeavor, but they’re pushing forward anyway.